OTC and ornithine carbamoyltransferase deficiency: TBG promoter with AMBP enhancer (680 bp) and Kozak-like sequence in the construct for the treatment of ornithine transcarbamylase deficiency (OTCD) (scAAV8.TBG.hOTCco) provides 60% of normal OTC activity on day 28 [225].